Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trial

Journal:

Nature Medicine

Published:

2025-10-21

DOI:

10.1038/s41591-025-03969-0

Affiliations:

4

Authors:

21

Go to article

Institutions	Authors	Share
The Wistar Institute, United States of America (USA)	8.000000	0.38
Hospital of the University of Pennsylvania, Penn, United States of America (USA)	5.000000	0.24
Inovio Pharmaceuticals, Inc.,, United States of America (USA)	5.000000	0.24
AstraZeneca Gaithersburg, MD, United States of America (USA)	3.000000	0.14

Interested in Medical Biotechnology?